# 12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.

> **NCT00069511** · PHASE2 · UNKNOWN · sponsor: **United Therapeutics** · enrollment: 72 (—)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** UT-231B

## Key facts

- **NCT ID:** NCT00069511
- **Lead sponsor:** United Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 72 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00069511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00069511, "12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00069511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*